{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:33:12Z","timestamp":1762900392676,"version":"build-2065373602"},"reference-count":4,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["New Microbes and New Infections"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.nmni.2023.101084","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T03:13:59Z","timestamp":1674184439000},"page":"101084","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Monkeypox breakthrough infections and side-effects: Clarion call for nex-gen novel vaccine"],"prefix":"10.1016","volume":"52","author":[{"given":"Ranjan K.","family":"Mohapatra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Snehasish","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali A.","family":"Rabaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aroop","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bijaya Kumar","family":"Padhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2695-8714","authenticated-orcid":false,"given":"Ranjit","family":"Sah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmni.2023.101084_bib1","article-title":"Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series","volume":"17","author":"Thornhill","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.nmni.2023.101084_bib3","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1001\/jama.2022.18320","article-title":"Human monkeypox virus infection in the immediate period after receiving modified vaccinia Ankara vaccine","volume":"328","author":"Hazra","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.nmni.2023.101084_bib4","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2211944","article-title":"Breakthrough infections after postexposure vaccination against mpox","author":"Thy","year":"2022","journal-title":"N\u00a0\u200bEngl J Med"},{"issue":"2","key":"10.1016\/j.nmni.2023.101084_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofv040","article-title":"Safety and immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic smallpox vaccine in vaccinia-naive and experienced human immunodeficiency virus-infected individuals: an open-label, controlled clinical phase II trial","volume":"2","author":"Overton","year":"2015","journal-title":"Open Forum Infect Dis"}],"container-title":["New Microbes and New Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2052297523000033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2052297523000033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:03:03Z","timestamp":1761854583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2052297523000033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":4,"alternative-id":["S2052297523000033"],"URL":"https:\/\/doi.org\/10.1016\/j.nmni.2023.101084","relation":{},"ISSN":["2052-2975"],"issn-type":[{"type":"print","value":"2052-2975"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monkeypox breakthrough infections and side-effects: Clarion call for nex-gen novel vaccine","name":"articletitle","label":"Article Title"},{"value":"New Microbes and New Infections","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmni.2023.101084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101084"}}